Literature DB >> 7561175

Anticryptococcal activity of NK cell-enriched peripheral blood lymphocytes from human immunodeficiency virus-infected subjects: responses to interleukin-2, interferon-gamma, and interleukin-12.

C A Horn1, R G Washburn.   

Abstract

Anticryptococcal activity of highly purified NK cells from patients with either early asymptomatic or late-stage human immunodeficiency virus (HIV) infection proved to be markedly impaired; activity was reproducibly restored to normal levels by in vitro addition of exogenous interleukin-12 (IL-12). For these highly purified NK cells, responses to IL-2 and interferon-gamma (IFN-gamma) among HIV-infected patients were variable, with only 2 of 8 exhibiting significant responses to IL-2 or IFN-gamma. In contrast, IL-2 and IFN-gamma consistently enhanced anticryptococcal activity of mixed lymphocyte populations, cells that more closely approximate the network likely to be operational in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561175     DOI: 10.1093/infdis/172.4.1023

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Recombinant human gamma interferon in human immunodeficiency virus-infected children: safety, CD4(+)-lymphocyte count, viral load, and neutrophil function (AIDS Clinical Trials Group Protocol 211).

Authors:  W T Shearer; M W Kline; S L Abramson; T Fenton; S E Starr; S D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Characterization of the cellular immune function of patients with chronic mucocutaneous candidiasis.

Authors:  D de Moraes-Vasconcelos; N M Orii; C C Romano; R Y Iqueoka; A J Duarte
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

Review 3.  Natural killer cells and antifungal host response.

Authors:  Stanislaw Schmidt; Stefanie-Yvonne Zimmermann; Lars Tramsen; Ulrike Koehl; Thomas Lehrnbecher
Journal:  Clin Vaccine Immunol       Date:  2013-01-30

4.  gamma Interferon gene expression and release in human lymphocytes directly activated by Cryptococcus neoformans and Candida albicans.

Authors:  S M Levitz; E A North
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

5.  The Frequency of Natural Killer Cell Subsets in Patients with Acquired Immune Deficiency Syndrome with Deep Fungal Infections.

Authors:  Gao Chen; Chun-Jun Qin; Meng-Zheng Wu; Fei-Fei Liu; Shu-Shu Liu; Li Liu
Journal:  Infect Drug Resist       Date:  2021-02-09       Impact factor: 4.003

6.  Mechanisms by Which Interleukin-12 Corrects Defective NK Cell Anticryptococcal Activity in HIV-Infected Patients.

Authors:  Stephen K Kyei; Henry Ogbomo; ShuShun Li; Martina Timm-McCann; Richard F Xiang; Shaunna M Huston; Anutosh Ganguly; Pina Colarusso; M John Gill; Christopher H Mody
Journal:  mBio       Date:  2016-08-23       Impact factor: 7.867

7.  Innate Immune Responses to Cryptococcus.

Authors:  Lena J Heung
Journal:  J Fungi (Basel)       Date:  2017-07-02

8.  Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida.

Authors:  Shu Shun Li; Henry Ogbomo; Michael K Mansour; Richard F Xiang; Lian Szabo; Fay Munro; Priyanka Mukherjee; Roy A Mariuzza; Matthias Amrein; Jatin M Vyas; Stephen M Robbins; Christopher H Mody
Journal:  Nat Commun       Date:  2018-02-21       Impact factor: 14.919

Review 9.  NK Cell Hyporesponsiveness: More Is Not Always Better.

Authors:  Marie Frutoso; Erwan Mortier
Journal:  Int J Mol Sci       Date:  2019-09-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.